Back to News & Events

Lahara Bio Presents at BIO International Convention

SBU Startup, Lahara Bio, presented in the start-up stadium event at the 2023 BIO International Convention in June.

Christopher Ashdown, a MD/PhD student at Stony Brook University, and Center for Biotechnology Program alumnus presented on behalf of Lahara after securing a spot in the coveted forum by winning multiple pitch competitions from NIH SEED office.

According to Ashdown, “Bio 2023 was an amazing experience, and I was thrilled to be able to share the exciting work that we’re doing at Lahara Bio with the greater bioscience community. The CfB was incredibly helpful in preparing the company for this conference and has done an excellent job of helping me develop on a personal/professional level”.

In addition to the main stage presentation, Ashdown also presented Lahara Bio at the NIH booth. Lahara Bio was sponsored to attend BIO by the NIH after Ashdown won the national investor pitch competition at the NIH Proof of Concept Network annual meeting this past spring.

Lahara Bio is an early-stage biotechnology company using cell-specific mechanical vibration to non-invasively improve biomanufacturing outcomes. Learn more about the company and the team behind Lahara at laharabio.com.

Related Stories

WP_Query Object
(
    [query] => Array
        (
            [post_type] => post
            [posts_per_page] => 3
            [post_status] => publish
            [orderby] => rand
        )

    [query_vars] => Array
        (
            [post_type] => post
            [posts_per_page] => 3
            [post_status] => publish
            [orderby] => rand
            [error] => 
            [m] => 
            [p] => 0
            [post_parent] => 
            [subpost] => 
            [subpost_id] => 
            [attachment] => 
            [attachment_id] => 0
            [name] => 
            [pagename] => 
            [page_id] => 0
            [second] => 
            [minute] => 
            [hour] => 
            [day] => 0
            [monthnum] => 0
            [year] => 0
            [w] => 0
            [category_name] => 
            [tag] => 
            [cat] => 
            [tag_id] => 
            [author] => 
            [author_name] => 
            [feed] => 
            [tb] => 
            [paged] => 0
            [meta_key] => 
            [meta_value] => 
            [preview] => 
            [s] => 
            [sentence] => 
            [title] => 
            [fields] => all
            [menu_order] => 
            [embed] => 
            [category__in] => Array
                (
                )

            [category__not_in] => Array
                (
                )

            [category__and] => Array
                (
                )

            [post__in] => Array
                (
                )

            [post__not_in] => Array
                (
                )

            [post_name__in] => Array
                (
                )

            [tag__in] => Array
                (
                )

            [tag__not_in] => Array
                (
                )

            [tag__and] => Array
                (
                )

            [tag_slug__in] => Array
                (
                )

            [tag_slug__and] => Array
                (
                )

            [post_parent__in] => Array
                (
                )

            [post_parent__not_in] => Array
                (
                )

            [author__in] => Array
                (
                )

            [author__not_in] => Array
                (
                )

            [search_columns] => Array
                (
                )

            [ignore_sticky_posts] => 
            [suppress_filters] => 
            [cache_results] => 1
            [update_post_term_cache] => 1
            [update_menu_item_cache] => 
            [lazy_load_term_meta] => 1
            [update_post_meta_cache] => 1
            [nopaging] => 
            [comments_per_page] => 50
            [no_found_rows] => 
            [order] => 
        )

    [tax_query] => WP_Tax_Query Object
        (
            [queries] => Array
                (
                )

            [relation] => AND
            [table_aliases:protected] => Array
                (
                )

            [queried_terms] => Array
                (
                )

            [primary_table] => wp_posts
            [primary_id_column] => ID
        )

    [meta_query] => WP_Meta_Query Object
        (
            [queries] => Array
                (
                )

            [relation] => 
            [meta_table] => 
            [meta_id_column] => 
            [primary_table] => 
            [primary_id_column] => 
            [table_aliases:protected] => Array
                (
                )

            [clauses:protected] => Array
                (
                )

            [has_or_relation:protected] => 
        )

    [date_query] => 
    [request] => SELECT SQL_CALC_FOUND_ROWS  wp_posts.ID
					 FROM wp_posts 
					 WHERE 1=1  AND wp_posts.post_type = 'post' AND ((wp_posts.post_status = 'publish'))
					 
					 ORDER BY RAND()
					 LIMIT 0, 3
    [posts] => Array
        (
            [0] => WP_Post Object
                (
                    [ID] => 3365
                    [post_author] => 3
                    [post_date] => 2019-09-20 17:23:10
                    [post_date_gmt] => 2019-09-20 17:23:10
                    [post_content] => The National Heart, Lung, and Blood Institute (NHLBI) Catalyze Program is soliciting applications for early stage translational research projects with the goal of developing basic scientific discoveries into viable therapeutics, devices, and diagnostics to treat heart, lung, blood, and sleep diseases and disorders.

Funding is available for early stage technology development, including:

Therapeutics (Small molecules/Biologics)
- Identifying and characterizing lead compounds

Devices/Diagnostics/Tools
- Developing, testing, and modifying prototypes
- Identifying and developing assay targets
- Developing research tools

Enabling Technologies and Transformative Platforms
- Developing highly-innovative, next-generation technologies that could transform current approaches to clinical practice or translational research (technology must be beyond proof-of-concept and should be ready to begin validation)
- Accelerating the areas of early detection and screening, animal model development, or clinical diagnosis

Learn more about the program and the informational webinar taking place on October 3, 2019 on the NHLBI website.
                    [post_title] => Funding Opportunity - NHLBI Catalyze Program
                    [post_excerpt] => Funding is available for early stage technology development through the National Heart, Lung, and Blood Institute (NHLBI) Catalyze Program.
                    [post_status] => publish
                    [comment_status] => open
                    [ping_status] => open
                    [post_password] => 
                    [post_name] => funding-opportunity-nhlbi-catalyze-program
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2019-09-20 17:23:10
                    [post_modified_gmt] => 2019-09-20 17:23:10
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://centerforbiotechnology.org/?p=3365
                    [menu_order] => 85
                    [post_type] => post
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [1] => WP_Post Object
                (
                    [ID] => 4725
                    [post_author] => 4
                    [post_date] => 2025-02-27 14:06:04
                    [post_date_gmt] => 2025-02-27 19:06:04
                    [post_content] => 

Stony Brook University faculty member and CFB supported researcher, Eric Brouzes, is leading a research to develop new testing methods for cervical cancer that do not require expensive equipment. The project has received a two-year grant of $50K per year from the Prevent Cancer Foundation.

Read more from SBU News: https://news.stonybrook.edu/university/new-test-for-cervical-cancer-tackles-healthcare-inequalities/

[post_title] => Stony Brook Research News: New Test for Cervical Cancer Tackles Healthcare Inequalities [post_excerpt] => [post_status] => publish [comment_status] => open [ping_status] => open [post_password] => [post_name] => brouzes-cervical-cancer-test [to_ping] => [pinged] => [post_modified] => 2026-03-16 14:27:42 [post_modified_gmt] => 2026-03-16 18:27:42 [post_content_filtered] => [post_parent] => 0 [guid] => https://centerforbiotechnology.org/?p=4725 [menu_order] => 0 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [2] => WP_Post Object ( [ID] => 3820 [post_author] => 4 [post_date] => 2021-09-20 15:59:29 [post_date_gmt] => 2021-09-20 15:59:29 [post_content] =>

NYSTAR and FuzeHub invite you to the New York State Innovation Summit on November 8-9, 2021 at the Turning Stone in Verona, NY. This multi-day event for NYS organizations that want to showcase and discover new and emerging technologies that support innovation and drive business growth. Whether you’re a startup, an economic developer, or an established manufacturer, the NYS Innovation Summit is for you.

The 2021 New York State Innovation Summit will showcase companies and researchers at the forefront of emerging technologies and new advancements in production capabilities. This event celebrates New York State leadership in technology-led economic growth with experts in biotechnology, new materials, energy innovation, and artificial intelligence that will explore current technology convergence opportunities, ways to accelerate commercialization, and issues of manufacturing sustainability.

This year’s Innovation Summit includes the New York State Commercialization Competition and speakers from top companies such as Cree, Plug Power, Velan Studios and Verizon 5G Labs.

For more information, or to register, visit nysinnovationsummit.com.

[post_title] => New York State Innovation Summit [post_excerpt] => NYSTAR and FuzeHub present the New York State Innovation Summit on November 8-9, 2021 at the Turning Stone in Verona, NY. [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => new-york-state-innovation-summit [to_ping] => [pinged] => [post_modified] => 2022-08-22 13:09:12 [post_modified_gmt] => 2022-08-22 13:09:12 [post_content_filtered] => [post_parent] => 0 [guid] => https://centerforbiotechnology.org/?p=3820 [menu_order] => 37 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) ) [post_count] => 3 [current_post] => -1 [before_loop] => 1 [in_the_loop] => [post] => WP_Post Object ( [ID] => 3365 [post_author] => 3 [post_date] => 2019-09-20 17:23:10 [post_date_gmt] => 2019-09-20 17:23:10 [post_content] => The National Heart, Lung, and Blood Institute (NHLBI) Catalyze Program is soliciting applications for early stage translational research projects with the goal of developing basic scientific discoveries into viable therapeutics, devices, and diagnostics to treat heart, lung, blood, and sleep diseases and disorders. Funding is available for early stage technology development, including: Therapeutics (Small molecules/Biologics) - Identifying and characterizing lead compounds Devices/Diagnostics/Tools - Developing, testing, and modifying prototypes - Identifying and developing assay targets - Developing research tools Enabling Technologies and Transformative Platforms - Developing highly-innovative, next-generation technologies that could transform current approaches to clinical practice or translational research (technology must be beyond proof-of-concept and should be ready to begin validation) - Accelerating the areas of early detection and screening, animal model development, or clinical diagnosis Learn more about the program and the informational webinar taking place on October 3, 2019 on the NHLBI website. [post_title] => Funding Opportunity - NHLBI Catalyze Program [post_excerpt] => Funding is available for early stage technology development through the National Heart, Lung, and Blood Institute (NHLBI) Catalyze Program. [post_status] => publish [comment_status] => open [ping_status] => open [post_password] => [post_name] => funding-opportunity-nhlbi-catalyze-program [to_ping] => [pinged] => [post_modified] => 2019-09-20 17:23:10 [post_modified_gmt] => 2019-09-20 17:23:10 [post_content_filtered] => [post_parent] => 0 [guid] => https://centerforbiotechnology.org/?p=3365 [menu_order] => 85 [post_type] => post [post_mime_type] => [comment_count] => 0 [filter] => raw ) [comment_count] => 0 [current_comment] => -1 [found_posts] => 282 [max_num_pages] => 94 [max_num_comment_pages] => 0 [is_single] => [is_preview] => [is_page] => [is_archive] => [is_date] => [is_year] => [is_month] => [is_day] => [is_time] => [is_author] => [is_category] => [is_tag] => [is_tax] => [is_search] => [is_feed] => [is_comment_feed] => [is_trackback] => [is_home] => 1 [is_privacy_policy] => [is_404] => [is_embed] => [is_paged] => [is_admin] => [is_attachment] => [is_singular] => [is_robots] => [is_favicon] => [is_posts_page] => [is_post_type_archive] => [query_vars_hash:WP_Query:private] => 325c4f9f1aebaa5ec90666fa54175ba0 [query_vars_changed:WP_Query:private] => [thumbnails_cached] => [allow_query_attachment_by_filename:protected] => [stopwords:WP_Query:private] => [compat_fields:WP_Query:private] => Array ( [0] => query_vars_hash [1] => query_vars_changed ) [compat_methods:WP_Query:private] => Array ( [0] => init_query_flags [1] => parse_tax_query ) [query_cache_key:WP_Query:private] => )

Funding Opportunity – NHLBI Catalyze Program

More Information

Stony Brook Research News: New Test for Cervical Cancer Tackles Healthcare Inequalities

More Information

New York State Innovation Summit

More Information